BRAF V600K Mutation Present
3 clinical trials · Condition
◉ Watch BRAF V600K Mutation Present
| Record | Firm | Date |
|---|---|---|
| Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer (NCT03975231) | City of Hope Medical Center | 2020-09-14 |
| Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02097225) | National Cancer Institute (NCI) | 2014-05-29 |
| Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery (NCT01940809) | National Cancer Institute (NCI) | 2013-08-28 |
Track BRAF V600K Mutation Present automatically
Every clearance here is in the API, with alerts when new ones post.